2/12
08:43 am
dgx
Quest Diagnostics (NYSE:DGX) had its price target raised by analysts at Mizuho from $210.00 to $235.00. They now have an "outperform" rating on the stock.
Low
Report
Quest Diagnostics (NYSE:DGX) had its price target raised by analysts at Mizuho from $210.00 to $235.00. They now have an "outperform" rating on the stock.
2/11
10:13 am
dgx
Quest Diagnostics (NYSE:DGX) had its "neutral" rating reaffirmed by analysts at UBS Group AG.
Low
Report
Quest Diagnostics (NYSE:DGX) had its "neutral" rating reaffirmed by analysts at UBS Group AG.
2/11
10:13 am
dgx
Quest Diagnostics (NYSE:DGX) was given a new $220.00 price target on by analysts at Evercore ISI.
Low
Report
Quest Diagnostics (NYSE:DGX) was given a new $220.00 price target on by analysts at Evercore ISI.
2/11
10:13 am
dgx
Quest Diagnostics (NYSE:DGX) was given a new $220.00 price target on by analysts at Truist Financial Corporation.
Low
Report
Quest Diagnostics (NYSE:DGX) was given a new $220.00 price target on by analysts at Truist Financial Corporation.
2/11
09:51 am
dgx
Quest Diagnostics (NYSE:DGX) had its price target raised by analysts at Barclays PLC from $210.00 to $225.00. They now have an "overweight" rating on the stock.
Low
Report
Quest Diagnostics (NYSE:DGX) had its price target raised by analysts at Barclays PLC from $210.00 to $225.00. They now have an "overweight" rating on the stock.
2/11
09:06 am
dgx
Quest Diagnostics (NYSE:DGX) was given a new $219.00 price target on by analysts at Robert W. Baird.
Low
Report
Quest Diagnostics (NYSE:DGX) was given a new $219.00 price target on by analysts at Robert W. Baird.
2/10
10:33 pm
dgx
Quest Diagnostics Q4 Earnings Call Highlights [Yahoo! Finance]
Low
Report
Quest Diagnostics Q4 Earnings Call Highlights [Yahoo! Finance]
2/10
04:06 pm
dgx
Quest Diagnostics Inc (DGX) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ... [Yahoo! Finance]
Low
Report
Quest Diagnostics Inc (DGX) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ... [Yahoo! Finance]
2/10
03:11 pm
dgx
Quest Diagnostics (NYSE:DGX) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
Low
Report
Quest Diagnostics (NYSE:DGX) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
2/10
01:32 pm
dgx
Quest Diagnostics (NYSE:DGX) had its price target raised by analysts at Citigroup Inc. from $190.00 to $215.00. They now have a "neutral" rating on the stock.
Low
Report
Quest Diagnostics (NYSE:DGX) had its price target raised by analysts at Citigroup Inc. from $190.00 to $215.00. They now have a "neutral" rating on the stock.
2/10
01:01 pm
dgx
Quest Diagnostics' Q4 Earnings & Revenues Beat Estimates, Stock Up [Yahoo! Finance]
Low
Report
Quest Diagnostics' Q4 Earnings & Revenues Beat Estimates, Stock Up [Yahoo! Finance]
2/10
12:26 pm
dgx
Quest Diagnostics Incorporated (DGX) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Low
Report
Quest Diagnostics Incorporated (DGX) Q4 2025 Earnings Call Transcript [Seeking Alpha]
2/10
11:57 am
dgx
Quest Diagnostics (DGX) Earnings Call Transcript [Yahoo! Finance]
Low
Report
Quest Diagnostics (DGX) Earnings Call Transcript [Yahoo! Finance]
2/10
08:24 am
dgx
Quest Diagnostics forecasts 2026 profit, revenue above estimates on lab test demand [Yahoo! Finance]
Medium
Report
Quest Diagnostics forecasts 2026 profit, revenue above estimates on lab test demand [Yahoo! Finance]
2/10
07:13 am
dgx
Quest Diagnostics: Q4 Earnings Snapshot [Yahoo! Finance]
Medium
Report
Quest Diagnostics: Q4 Earnings Snapshot [Yahoo! Finance]
2/10
06:47 am
dgx
Quest Diagnostics Reports Fourth Quarter and Full Year 2025 Financial Results; Provides Guidance for Full Year 2026; Increases Quarterly Dividend 7.5% to $0.86 Per Share
Medium
Report
Quest Diagnostics Reports Fourth Quarter and Full Year 2025 Financial Results; Provides Guidance for Full Year 2026; Increases Quarterly Dividend 7.5% to $0.86 Per Share
2/10
06:33 am
dgx
Quest Diagnostics Increases Dividend 7.5% To $0.86 Per Quarter, Marking 15 Consecutive Years of Dividend Increases; Announces $1 Billion Increase in Share Repurchase Authorization
Medium
Report
Quest Diagnostics Increases Dividend 7.5% To $0.86 Per Quarter, Marking 15 Consecutive Years of Dividend Increases; Announces $1 Billion Increase in Share Repurchase Authorization
2/10
05:36 am
dgx
The Great AI Squeeze: High Costs Take Center Stage In Hyperscalers' Earnings Reports [Seeking Alpha]
Medium
Report
The Great AI Squeeze: High Costs Take Center Stage In Hyperscalers' Earnings Reports [Seeking Alpha]
2/3
07:55 pm
dgx
Is Quest Diagnostics (DGX) Still Attractive After Recent Share Price Strength? [Yahoo! Finance]
Low
Report
Is Quest Diagnostics (DGX) Still Attractive After Recent Share Price Strength? [Yahoo! Finance]
2/2
09:01 am
dgx
Quest Diagnostics Launches Novel Flow Cytometry MRD Blood Test for Myeloma, Enabling Ultrasensitive Detection of Residual Disease [Yahoo! Finance]
Low
Report
Quest Diagnostics Launches Novel Flow Cytometry MRD Blood Test for Myeloma, Enabling Ultrasensitive Detection of Residual Disease [Yahoo! Finance]
2/2
08:52 am
dgx
Quest Diagnostics Launches Novel Flow Cytometry MRD Blood Test for Myeloma, Enabling Ultrasensitive Detection of Residual Disease
Low
Report
Quest Diagnostics Launches Novel Flow Cytometry MRD Blood Test for Myeloma, Enabling Ultrasensitive Detection of Residual Disease
1/30
07:00 am
dgx
Quest Diagnostics (NYSE:DGX) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating. They now have a $210.00 price target on the stock.
Low
Report
Quest Diagnostics (NYSE:DGX) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating. They now have a $210.00 price target on the stock.
1/25
03:05 am
dgx
Quest Diagnostics (NYSE:DGX) was downgraded by analysts at
Wall Street Ze
Low
Report
Quest Diagnostics (NYSE:DGX) was downgraded by analysts at
Wall Street Ze
1/21
03:03 pm
dgx
Quest Diagnostics Named to Fortune's World's Most Admired Companies List for 12th Consecutive Year [Yahoo! Finance]
Low
Report
Quest Diagnostics Named to Fortune's World's Most Admired Companies List for 12th Consecutive Year [Yahoo! Finance]
1/21
02:35 pm
dgx
Quest Diagnostics Named to Fortune's World's Most Admired Companies List for 12th Consecutive Year
Low
Report
Quest Diagnostics Named to Fortune's World's Most Admired Companies List for 12th Consecutive Year